Bocouture Provides Advantages of

36 year old female before Tx
36 year old female two weeks after Bocouture Tx
Photos courtesy of David Eccleston, M.D., M.B., Ch.B.,
M.B.A.C.D., M.S.C.P.S.
36 year old female before Tx
36 year old female two weeks after Bocouture Tx
Photos courtesy of David Eccleston, M.D., M.B., Ch.B.,
M.B.A.C.D., M.S.C.P.S.
3 THE European Aesthetic Guide Spring 2011 www.miinews.com
treatment regimes. “You can’t have a
1:1 conversion with other neurotoxin
products, and there is no fixed dosage
conversion ratio,” explained
David Eccleston, M.D., M.B., Ch.B.,
M.B.A.C.D., M.S.C.P.S., clinical director
of MediZen, Ltd. (Mere Green,
Sutton Coldfield, U.K.). “Most physicians
are using a 2.5:1 or 3:1 ratio
with other neurotoxins versus Bocouture
or Vistabel. There is no proven
equivalence.”
David Eccleston, M.D., M.B.,
Ch.B., M.B.A.C.D., M.S.C.P.S.
Clinical Director
MediZen, Ltd.
Mere Green, Sutton Coldfield, U.K.
Dr. Eccleston also noted that an experienced
injector can easily begin using
Bocouture and can expect results
similar to those achieved with other
neurotoxins on the market. “I’ve been
using neurotoxins for 16 years and I
believe that Bocouture is a useful tool
to have in my arsenal. In my opinion, it
delivers equivalent efficacy and tolerability
to Vistabel; therefore, I believe
Bocouture is here to stay,” he said.
Other advantages of Bocouture include
a fast onset of effect from day
one onwards. 3 As well; its ability to
maintain stability at room temperature
for three years means that it does not
require a cold chain and does not
have to be stored in a refrigerator.
To date, for aesthetic use, Bocouture
is marketed in Germany, the U.K.,
France, Spain, Italy, the Netherlands
and Belgium. The product is marketed
as Xeomin in Russia and Argentina,
and as Xeomeen in Mexico. Botulinum
toxin type A preparations from Merz
have been used in therapeutic and aesthetic
indications in more than 120,000
patients worldwide and in more than
1,500 patients in clinical trials. Safety
and efficacy have been successfully
demonstrated in both indications.
According to experts there is a
growing trend for full-face treatments 5 .
This trend is supported by the Merz
Aesthetics Face Value Beauty Survey
conducted by Harris Interactive among
2,900 women 6 located in France, Italy,
Spain, Russia and the U.K. The survey
revealed that patients most often see
their physician for multiple problem areas.
Additionally, approximately one in
two patients decided to treat other areas
after consulting with their physician
or aesthetic practitioner.
Given that nearly half of women want
to improve or change wrinkles around
their eyes, mouth or in their forehead,
it can be expected that botulinum toxin
will maintain its position as a core
tool in aesthetics with interest also
continuing to increase in other therapeutic
areas.
*Bocouture is indicated for the temporary
improvement in the appearance of moderate
to severe vertical lines between the eye brow
seen at frown, in adults